Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Fluoguide AS

FLUO
Current price
33.9 SEK +0.65 SEK (+1.95%)
Last closed 34.05 SEK
ISIN DK0061123312
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 460 194 179 SEK
Yield for 12 month -60.85 %
1Y
3Y
5Y
10Y
15Y
FLUO
21.11.2021 - 28.11.2021

FluoGuide A/S, a clinical stage biotechnology company, focused on developing drugs for surgical outcomes by making cancer fluorescent in Denmark. Its lead product candidate is FG001, which is in Phase IIa and IIb for the treatment of high-grade glioma; Phase II clinical trial for the treatment of lung cancer, and head and neck cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. It has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; collaboration with Copenhagen University Hospital; collaboration with Intuitive Surgical, Inc. for robotics surgery in head and neck cancer. FluoGuide A/S was incorporated in 2018 and is headquartered in Copenhagen, Denmark. Address: Ole MaalOees Vej 3, Copenhagen, Denmark, 2200

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1 459.27 SEK

P/E ratio

Dividend Yield

Current Year

+663 895 SEK

Last Year

+10 218 898 SEK

Current Quarter

+1 569 479 SEK

Last Quarter

+40 807 SEK

Current Year

+663 895 SEK

Last Year

+10 218 898 SEK

Current Quarter

+1 569 479 SEK

Last Quarter

+40 807 SEK

Key Figures FLUO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -40 541 215 SEK
Operating Margin TTM -811.6 %
PE Ratio
Return On Assets TTM -82.96 %
PEG Ratio
Return On Equity TTM -136.82 %
Wall Street Target Price 1 459.27 SEK
Revenue TTM 1 240 127 SEK
Book Value 3.02 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 528.9 %
Dividend Yield
Gross Profit TTM 6 596 787 SEK
Earnings per share -4.72 SEK
Diluted Eps TTM -4.72 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics FLUO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History FLUO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation FLUO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 371.0863
Enterprise Value EBITDA -13.6259
Price Book MRQ 7.9254

Financials FLUO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators FLUO

For 52 weeks

33.03 SEK 88.55 SEK
50 Day MA 39.67 SEK
Shares Short Prior Month
200 Day MA 46.25 SEK
Short Ratio
Shares Short
Short Percent